Denali Therapeutics Inc. is seeking a Principal Scientist to provide strategic leadership in late-phase and commercial analytical development and extended characterization.
You will oversee control strategy development at CDMOs and deliver across CQAs, bridging, and validation activities while mentoring junior staff. You will develop and optimize MS- and chromatographic-based methods, perform in-depth physicochemical characterization, and drive regulatory-ready documentation for health authority
#J-18808-Ljbffr
Are you ready to take on the Senior Scientist, Late-Phase Analytics & Formulation role at Denali Therapeutics Inc?
The position is based in South San Francisco, CA, United States.
This opportunity is part of our work in Bio & Pharmacology & Health, Other.
The advertised compensation is 159.000 - 207.000.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.